Paulson controls 4% of Grifols


According to sources familiar with the matter, the US hedge fund management firm Paulson & Co has increased its stake in the Spanish blood derivatives specialist Grifols by 1.3 percentage points to 4% of capital, Cotizalia reports. Its exposure to the business now totals USD390m.